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Hypocholesteremlc Effect of Phenoxybenzamine
(Dibenzyline), An Adrenerglc Blocking Agent
EXPERIMENTAL STUDIES WITH MONKEYS AND HUMAN VOLUNTEERS
By S. N. Jagannathan, M.Sc, S. G. Srikantia, B.Sc, M.B.B.S.,
and C. Gopalan, M.D., Ph.D.
• The possible contribution of emotional
stress and strain to the development of coro-
nary artery disease has been frequently sug-
gested, hut precise proof of this is hard to
obtain. In view of the difficulty inherent in
properly denning what constitutes emotional
stress, let alone measuring it, progress in this
field of research has perforce been slow. There
have been some studies, however, pointing to
the influence of acute mental stress on serum
cholesterol levels.'^1 While the exact biochemi-
cal equivalent of mental stress has not been
clearly established, it is generally agreed that
acute emotional states are associated with an
increased secretion of epinephrine. Bogdonoff
et al.5 found that emotional episodes caused
rapid mobilization of unesterified fatty acids
from the body tissues into the circulation;
similar results were found with infusions of
epinephrine and norepinephrine. It has been
reported" that deposition of cholesterol in the
intima is accelerated and intensified by epi-
nephrine, and the catecholamine-phospholipid
compounds seem to possess a particular affin-
ity for arterial tissues.
The present study was originally under-
taken with a view to elucidating the possible
role of epinephrine in influencing serum cho-
lesterol levels. "While the experiments reported
here have not been able to provide evidence
for the role of emotional stress and epineph-
rine in atherosclerosis, they have yielded some
new information regarding the effect of some
substances on serum cholesterol levels.
Methods
The effect on serum cholesterol, in human sub-
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jeets and in monkeys, of supplementing high-fat
diets with Dibenzyline,0 an ornlly effective udren-
crgic blocking agent, which acts by inhibiting tho
response of effector cells to the action of circu-
lating epinephrine, was studied. In addition, the
effect of the phonoxyethyl analogue of Diben-
zyline, G-D 131,T which does not possess the ad-
renergic blocking property, but has been shown7' s
to possess the other actions of Dibenzyline, was
also investigoted. The following experiments were
carried out:
EXPERIMENT I t EFFECT OF SERUM
CHOLESTEROL OF SUPPLEMENTATION
OF DIBENZYLINE OR O-D 131 TO
MONKEYS ON A HIGH-FAT DIET
Twenty-one adult male monkeys (Maciica rudi-
uta) maintained on an adequate stock diet con-
taining 8 per cent fat for a period of not less than
four weeks were divided into three groups of seven
animals each, with respect to an even distribution
of body weights and initial levels of serum cho-
lesterol. The animals were fed n high-fat diet for
a period of five weeks, at the end of which their
serum cholesterol levels were determined. After
this initial period, group 1 was continued on the
same high-fat diet and served as control, whereas
groups 2 and 3 were given, in addition to the
high-fat diet, 5 mg. per day of Dibenzyline and
G-D 131, respectively. The diets were of 'liquid-
formula type" and contained skimmed-milk pow-
der, 48 per cent; coconut oil, 25 per cent; vitamin
mixture, 1 per cent;t salt mixture,§ 1.2 per cent;
•Phenoxybenzainine—Dibenzj'line capsules kindly
doutod by Smith, Kline nnd French Laboratories Ltd.,
England.
tN- (2-cliloroethyl) -N- (cyclohexylmethyl) -cthylainiiio
hydrochloride.
{Provided per Kg. diet, tho following vitamins
in ing.: Thiainine HC1, 5; riboflavin, 8; niacin, 25;
pyridoxine HC1, 5; calcium pantothenute, 25; f olic
ncid, 2; menadione, 20; inositol, 100; nnd para-
aininobenzoic acid, 100. Vitamin A, 7000 I.TJ., and
vitamin C, 50 nig., wore included in the daily diet
of each monkey.
§Coiupoaed of, in Gm.: Potassium phosphate, 3GG;
magnesium sulfate, 160; ferrous sulfnto, 70; sodium
chloride, 104; and potassium iodide, 10.
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TABLE 1
Effect of Administration of Dibenzyline (Phenoxybenzamine) and Its Phenoxyethyl
Analogue, G-D 131, on Serum Cholesterol Levels of Monkeys Fed a High-Fat Diet*
Group
1
2
3
Drug
supplement
Nil
Dibenzyliue
Q-D 131
Number
of
monkeys
7
7
7
Serum cholesterol, me./lOO ml.
Initial
low-fat
period level
149.0
±9.13t
137.1
±6.42
143.6
±7.37
Level 6
weeks after
hlffh-fat diet
179.4
±8.74
166.7
±10.70
176.6
±7.68
Change In
level after 26
days of drug:
supplementation
+ 0.86
± 4.76
—13.71
±13.76
—21.0
± 1.56
Significance of
the change In
serum cholesterol
after druff
supplementation
Not significant
P <0.02
p <o.ooat
"The diet contained coconut oil at a level of 25 per cent, supplying 45 per cent of total
calories.
t Standard error of the mean.
}The difference between the Dibenzyline group and G-D 131 group was not significant.
choline-stnrch mixture, 1 per cent;' and sucrose,
23.8 per cent. The diets were administered to the
animals by means of a stomach tube. Four animals
in each group were given the daily feed in a
single dose, while the other three animals re-
ceived the same amount of diet in two equally
divided doses, four hours apart. The details of
the preparation and administration of the liquid
diets have been described previously (Jagan-
nathan0). Dibenzyline and G-D 131 were added
daily to the diet at the time of feeding. The three
groups of animals were maintained on their re-
spective diets for a period of 25 days, at the end
of which their serum cholesterol levels were de-
termined.
EXPERIMENT 3: EFFECT OF DIBENZYLINE
ON THE INCREASE OF SERUM CHOLES-
TEROL IN MONKEYS MAINTAINED
ON A HIGH-CHOLESTEROL
HIGH-FAT DIET
Six adult male monkeys were divided into two
groups of three animals each. Group 1 was fed a
diet containing wheat flour, 52.3 per cent; casein,
12 per cent; salt mixture,10 4 per cent; vitamin
mixture, 1 per cent; choline chloride, 0.2 per cent;
hydrogenated groundnut (peanut) fat, 30 per cent;
and cholesterol, 0.5 per cent. Group 2 was fed the
same high-cholesterol, high-fat diet plus a supple-
ment of 5 mg. Dibenzyline per animal per day.
Serial determinations of serum cholesterol levels
were done once in two weeks over a period of 15
weeks. Two monkeys, one from each group, were
sacrificed at the end of 90 days and the other
animals at the end of 105 days. The aortae were
taken out and examined histologically for evi-
dence of atheroma.
•Supplied 0.2 per cent of choline chloride in the
diet
EXPERIMENT 3i EFFECT OF DIBENZYLINE
ON SIRUM CHOLESTEROL LEVELS
AND FECAL EXCRETION OF BILE
ACIDS IN HUMAN SUBJECTS
RECEIVING A HIGH-
BUTTERFAT DIET
Three normal healthy human subjects, aged 25
years, were fed a diet providing about 3,000 cal-
ories, 90 Gm. protein, and 120 Gm. butterfat daily
for a period of 32 days. Serum cholesterol levels
were determined on two successive days before the
experimental diet was started (initial values) and
again at the end of 8 and 11 days on the experi-
mental high-fat diet (end of period I ) . From the
twelfth to the twenty-third day (period II) , the
subjects received an oral supplement of 10 mg.
Dibenzyline a day and serum cholesterol levels
were estimated after 8 and 11 days in this period.
The Dibenzyline was then replaced by a placebo,
but the fat diet was continued (period III) .
Serum cholesterol levels were again determined
on the thirty-first and thirty-second days. Twenty-
four hours' fecal output on the last three days
of periods I and H was collected and duplicate
samples were analyzed for the bile acids, cholio
and dihydroxycholanic (deoxycholic and cheno-
deoxycholic) acids, and Liebermann-Burehard
chromogens.
The determination of serum cholesterol was car-
ried out according to the method of Abell et al.11
Cholic acid and dihydroxycholanic acids were de-
termined in the feces by using the spectrophoto-
metric method of Kier,12 along with the modifi-
cations suggested by Mosbach et al.18 and Haust
and Beveridge.14
Results and Discussion
EXPERIMENT 1
The results are presented in table 1.
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TABU a
Effect of Dibenzyline on the Elevation of Serum Cholesterol in Monkeys Fed a High-Cholesterol,
High-Fat Diet
Serum cholesterol, mg./lOO mL
Group
1 Control
2 Dibenzyline-
supplemented
Monkey no.
1
2
3
Mean
1
2
3
Mean
Initial
level
49
93
175
106
93
103
63
86
16
days
173
219
386
269
136
132
87
118
80
days
250
314
391
318
207
214
237
219
Inoreaae from
60
days
401
417
481
433
317
481
398
399
the Initial level
76
days
457
535
561
518
366
636
485
496
sodays
457
639
499
532
375
629
581
528
106
days
*
562
522
542
•
496
521
509
•These two animals were killed at the end of 90 days on the experimental diet.
The mean serum cholesterol values in the
three groups, before initiation of the high-fat
diet, were 149.0 ± 9.13,* 137.1 ± 6.42, and
143.6 ± 7.87 mg./lOO ml. By the end of five
weeks on the high-fat diet, the serum choles-
terol levels had increased in all the animals
and averaged 179.4 ± 8.74, 166.7 ± 10.70, and
176.6 ± 7.68 mg./lOO ml., respectively, in the
three groups. During the experimental drug-
administration period, the control group of
monkeys (group 1) showed a mean elevation
of 0.86 mg./lOO ml. On the other hand, group
2, receiving the Dibenzyline, showed a mean
depression in serum cholesterol of the order
of 13.7 mg./lOO ml. The administration of the
phenoxyethyl analogue of Dibenzyline, G-D
131, to the animals of group 3 also brought
about a reduction in serum cholesterol of the
order of 21 mg./lOO ml. Analysis of variance
of the changes in serum cholesterol during
the drug administration period showed that
the differences due to the administration of
the drugs were statistically significant at the
1 per cent level (F = 9.74, Degrees of Free-
dom 17 and 2) and the differences due to the
mode of feeding of the diet were found to be
not significant (F = 3.76 for Degrees of
Freedom 17 and 1). Hence, combining the
dietary groups irrespective of whether the
diet was fed as a single dose or divided
doses, it was found by f-test that, while the
'Standard error.
control animals did not show significant
changes during the experimental period, those
receiving Dibenzyline and G-D 131 as sup-
plements showed a significant (P <0.02 and
P <0.OOl, respectively) depression in serum
cholesterol. The values of the Dibenzyline-
and G-D 131-fed groups were not signifi-
cantly different. Since the increase in the
serum cholesterol brought about by a high-
fat diet was significantly lowered, even with
the administration of the analogue of Diben-
zyline (G-D 131, which does not possess the
adrenergic blocking property), it would ap-
pear that the hypocholesteremic action of
Dibenzyline is independent of its adrenergic
blocking effect. It may be pointed out that
the addition of these drugs did not have any
influence on the body weight of these animals
over the experimental period.
EXPERIMENT 2
The results of this study are given in table
2. The mean serum cholesterol levels of the
two groups over the different durations of
feeding have been plotted in figure 1. It can
be seen from table 2 and figure 1 that the
hypocholesteremic effect of Dibenzyline could
be seen even when the diet contained choles-
terol. The increase in serum cholesterol was
retarded by the presence of Dibenzyline in
the diet of monkeys on a high-cholesterol,
high-fat diet, during the first 60 days, but
with the continuation of the experiment for
Circulation Research, Volume XI, December 198B
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Effect of Dibenzyline on the increase of serum
cholesterol levels in monkeys on a high-cholesterol,
high-fat diet.
longer periods, the differences in serum choles-
terol between the control and supplemented
groups tended to narrow.
None of the monkeys killed at the end of
the experimental period showed any histo-
logical evidence of atheroma in the aorta, even
though the maximum serum cholesterol levels
reached in the different animals ranged from
468 mg. to 739 mg./lOO ml. It should be
pointed out that the hypercholesteremia in-
duced in these animals is of a high degree,
considering the level of dietary cholesterol
(0.5 per cent) fed. Cox et al.15 have re-
ported development of atheromas in monkeys
whose mean cholesterol levels were main-
tained between 256 and 393 mg. per cent for
six months or more. In the present experi-
ment, where, between 30 days and 105 days
of the experimental period, the monkeys had a
mean cholesterol level well exceeding 500 mg.
per cent, the duration of this hypercholes-
teremic state (viz. 2% months) was probably
not enough for atherogenesis.
EXPERIMENT 3
The results of this investigation are indi-
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FIGURE 3
Effect of Dibensyline, 10 mg./day, on senim cho-
lesterol and fecal excretion of bile acids in normal
human subjects on a high-butterfat diet. The
duration of each period was 11 days. The serum
cholesterol values plotted are the mean of tivo
determinations done 8 and 11 days after each die-
tary period. Period I is the initial butterfat pe-
riod; period II, the Dibenssyline-supplemented
period; period III, the placebo-supplemented pe-
riod. Deoxycholic acid values include chenodeoxy-
cholic acid also, representing the dihydroxycholunic
acids.
cated in figure 2. In this investigation, in
which human volunteers were used, two of
the subjects, B and M, responded to the
high-butterfat intake with an increase in
serum cholesterol (from 160 to 193 mg. per
cent in B and from 173 to 184 mg. per
cent in M), which was reduced following
Dibenzyline supplementation in one (to 175
mg. per cent in B), but not in the other
(189 mg. per cent in M). Following the
withdrawal of the drug, the serum cholesterol
in subject B, whicli had shown a fall, returned
to the pre-Dibenzyline level (192 mg. per
cent). The third subject (C) showed no in-
crease in serum cholesterol with the experi-
mental high-fat diet as compared with the
value on his home diet, but showed a lowering
(from 142 to 130 mg. per cent) when Diben-
zyline was given in addition, and a prompt
return to a higher value (149 mg. per cent)
following withdrawal of the drug.
All three subjects showed au increase (M, 36
per cent; B, 48 per cent; and C, 87 per cent)
in the fecal excretion of total bile acids, cholic
and dihydroxycholanic (deoxycholie plus ehe-
nodeoxyeholie) acids during the Dibenzyline-
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supplemented period, at the end of which
two of them showed a reduction in serum
cholesterol levels. Subjects B and C, who
responded to the administration of the drug
by way of definite decreases in their serum
cholesterol levels, showed greater increase
in the excretion of dihydroxycholanic acids
than in that of cholic acid (68 per cent
and 21 per cent, respectively, in B, and 99
per cent and 78 per cent in C). Subject M,
on the other hand, showed equal increases
(35 to 37 per cent) in the excretion of both
cholic acid and dihydroxycholanic acids. The
fact that subject M showed an increase in
fecal bile acids during the Dibenzyline period
and yet did not show a decrease in serum
cholesterol may suggest that, but for the
Dibenzyline administration, his serum choles-
terol would have continued to rise to a sig-
nificantly higher level on the high-butterfat
diet. The excretion of the Liebermann-
Burchard chromogens was not affected to a
significant extent (no change in B and 11
per cent decrease in M and C) due to the
administration of Dibenzyline. These observa-
tions suggest that the hypocholesteremic
action of Dibenzyline may be mediated, at
least partly, through an increase in the syn-
thesis of bile acids from cholesterol and their
consequent enhanced fecal elimination.
As stated before, these investigations were
originally planned to discover the possible
role of emotional stress and the consequent
increased circulating epinephrine in the causa-
tion of cholesterolemia. Since the adrenergie
blocking agent used here, Dibenzyline, had
hypocholesteremic action unconnected with its
action of adrenergic blockade, the elucidation
of the aspect of emotional stress and choles-
terol levels was not possible in this study.
The study has, however, demonstrated the
hypocholesteremic effect of Dibenzyline and
its analogue.
The relative merit of Dibenzyline as com-
pared with the other well-known hypocholes-
teremic agents may be investigated in patients
with hypercholesteremia. It was noted that
as low as 10 mg. of the drug given for a
Circulation Research, Volume XI, December 1961
short period of 11 days was quite effective in
reducing the moderate hypercholesteremia in-
duced by a high-fat intake in our subjects.
Even on this low dosage level of Dibenzyline,
evidence of adrenergic blockade was present
—the feeling of nasal congestion and a mod-
erate sense of fatigue being complained of
by all three subjects. There was, in addition,
a slight fall in the blood pressure.
Summary
The effect of an orally effective adrenergic
blocking agent, Dibenzyline, on serum choles-
terol levels was studied in human subjects
and in monkeys on high-fat diets. In addition,
the effect of the phenoxyethyl analogue of
Dibenzyline, G-D 131, was also investigated
in monkeys.
The studies showed that the increase in
serum cholesterol level brought about by a
high-fat diet in monkeys could be consid-
erably reduced by supplementation with
Dibenzyline. This hypocholesteremic action
was also observed with the analogue of
Dibenzyline, G-D 131, which does not possess
the adrenergic blocking property. It appears,
therefore, that the hypocholesteremic action
of Dibenzyline is independent of its adren-
ergic blocking activity. AVhen a high-fat diet
which also contained a high amount of cho-
lesterol was used, Dibenzyline retarded the
increase in serum cholesterol of monkeys for
a considerable length of time.
Administration of Dibenzyline, 10 mg. daily
for 11 days, brought about a fall in serum
cholesterol in two of the three human sub-
jects and arrested the further increase in
serum cholesterol in the third subject on a
high-butterfat diet. All the subjects showed
increased fecal elimination of cholic and dihy-
droxycholanic acids during the Dibenzyline-
supplemented period, suggesting that the
hypocholesteremic effect of the drug is at
least partlj' mediated through increased elim-
ination of cholesterol as bile acids.
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Book Review
The Human Pulmonary Circulation: Its Form
and Function in Health and Disease, Peter
Harris and Donald Heath. Baltimore, Williams
& Wilkins Co., 1962, 354 pages. $13.00.
This is the fourth monograph on the pulmonary
circulation which has appeared in recent years.
The outstanding feature of this one is the excel-
lent correlation between the pathology nnd clinical
physiology of the human pulmonary circulation.
The first third of the book consists of n systematic
discussion of clinical measurements of pressure,
flow, blood volume, resistance, and impedance in
the pulmonary circulation. The rest of the mono-
graph is devoted to various diseases in which the
pulmonary vessels are abnormal in structure and
function.
The authors should be congratulated for pos-
sessing the ability to sort out the settled facts from
controversies. The latter were minimized by de-
voting the monograph to studies of the human
lung and omitting the studies on other species.
Some renders will undoubtedly wonder if there is
any important functional difference between the
pulmonaiy circulation of man nnd nnimnls. They
will have to secure an unbiased answer elsewhere.
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